# OnCo record ipsoprubart (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ipsoprubart/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ipsoprubart" ;
  schema:name "Ipsoprubart"@en ;
  schema:alternateName "ELA026"@en ;
  schema:description "Ipsoprubart is an experimental antibody from Electra Therapeutics, in phase 1 trials for relapsed or refractory T-cell and NK-cell cancers."@en ;
  schema:url <https://onco.cc/drugs/ipsoprubart/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://electra-therapeutics.com/ipsoprubart/>, <https://www.sec.gov/Archives/edgar/data/2088082/000119312526395670/d61940d424b4.htm>, <https://clinicaltrials.gov/study/NCT07465835> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Monoclonal antibody" ;
  onco:targets <https://onco.cc/targets/sirpa/> ;
  onco:companies <https://onco.cc/companies/electra-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07465835/> .